Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,590 | 238 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Collegium Pharmaceutical, Inc. | $663.92 | 39 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $427.71 | 29 | $0 (2020) |
| Abbott Laboratories | $425.76 | 15 | $0 (2021) |
| Medtronic USA, Inc. | $326.21 | 9 | $0 (2019) |
| BioDelivery Sciences International, Inc. | $288.60 | 23 | $0 (2021) |
| Daiichi Sankyo Inc. | $264.74 | 20 | $0 (2019) |
| ARBOR PHARMACEUTICALS, INC. | $254.14 | 14 | $0 (2021) |
| GlaxoSmithKline, LLC. | $241.31 | 2 | $0 (2023) |
| INSYS Therapeutics Inc | $206.19 | 15 | $0 (2018) |
| Medtronic, Inc. | $204.38 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $116.59 | 1 | GlaxoSmithKline, LLC. ($116.59) |
| 2022 | $159.41 | 2 | GlaxoSmithKline, LLC. ($124.72) |
| 2021 | $741.04 | 32 | Abbott Laboratories ($295.37) |
| 2020 | $212.47 | 12 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($64.03) |
| 2019 | $975.08 | 53 | Collegium Pharmaceutical, Inc. ($163.69) |
| 2018 | $1,661 | 88 | Collegium Pharmaceutical, Inc. ($317.43) |
| 2017 | $723.79 | 50 | INSYS Therapeutics Inc ($192.79) |
All Payment Transactions
238 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/02/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $116.59 | General |
| Category: VACCINES | ||||||
| 12/01/2022 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $34.69 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/04/2022 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $124.72 | General |
| Category: VACCINES | ||||||
| 11/22/2021 | Abbott Laboratories | Proclaim IPG (Device) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Neuromodulation | ||||||
| 11/15/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: Chronic Pain | ||||||
| 11/11/2021 | Abbott Laboratories | Proclaim IPG (Device) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Neuromodulation | ||||||
| 11/05/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $22.16 | General |
| Category: Opioid Analgesic | ||||||
| 11/02/2021 | Abbott Laboratories | Octrode SCS Leads (Device) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Neuromodulation | ||||||
| 10/11/2021 | Abbott Laboratories | Proclaim IPG (Device) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Neuromodulation | ||||||
| 10/08/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $21.73 | General |
| Category: Opioid Analgesic | ||||||
| 10/07/2021 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Sleep | ||||||
| 09/23/2021 | Abbott Laboratories | Proclaim IPG (Device) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Neuromodulation | ||||||
| 09/21/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Chronic Pain | ||||||
| 09/15/2021 | Abbott Laboratories | Octrode SCS Leads (Device) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Neuromodulation | ||||||
| 09/10/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.12 | General |
| Category: Opioid Analgesic | ||||||
| 09/08/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Chronic Pain | ||||||
| 08/24/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Chronic Pain | ||||||
| 08/16/2021 | SI-BONE, INC. | IFUSE IMPLANT (Device) | Food and Beverage | Cash or cash equivalent | $15.60 | General |
| Category: SACROILIAC JOINT DYSFUNCTION | ||||||
| 08/07/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $13.18 | General |
| Category: Opioid Analgesic | ||||||
| 07/29/2021 | Abbott Laboratories | Prodigy Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Neuromodulation | ||||||
| 07/20/2021 | Medtronic, Inc. | KYPHON Balloon Kyphoplasty (Device) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 07/16/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $20.70 | General |
| Category: Opioid Analgesic | ||||||
| 06/30/2021 | Abbott Laboratories | Octrode SCS Leads (Device) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Neuromodulation | ||||||
| 06/25/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.47 | General |
| Category: Opioid Analgesic | ||||||
| 06/16/2021 | Abbott Laboratories | Octrode SCS Leads (Device) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Neuromodulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 16 | 827 | 2,235 | $843,386 | $166,538 |
| 2020 | 16 | 1,269 | 3,731 | $1.3M | $241,097 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 248 | 1,001 | $400,600 | $94,617 | 23.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 211 | 556 | $145,227 | $37,938 | 26.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 141 | 303 | $145,095 | $18,828 | 13.0% |
| 62323 | Injection of substance into spinal canal of lower back or sacrum using imaging guidance | Facility | 2021 | 33 | 38 | $31,157 | $2,734 | 8.8% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance | Facility | 2021 | 12 | 13 | $23,888 | $2,255 | 9.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 24 | 24 | $9,334 | $1,789 | 19.2% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 25 | 31 | $13,660 | $1,571 | 11.5% |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance, single level | Facility | 2021 | 14 | 15 | $14,847 | $1,383 | 9.3% |
| 27096 | Injection procedure into sacroiliac joint for anesthetic or steroid | Facility | 2021 | 15 | 16 | $13,139 | $1,165 | 8.9% |
| 64493 | Injections of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2021 | 12 | 15 | $12,736 | $1,105 | 8.7% |
| 62321 | Injection of substance into spinal canal of upper or middle back using imaging guidance | Facility | 2021 | 13 | 14 | $12,417 | $1,060 | 8.5% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves with imaging guidance | Facility | 2021 | 11 | 15 | $7,385 | $714.15 | 9.7% |
| 64484 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance, each additional level | Facility | 2021 | 14 | 15 | $6,433 | $643.72 | 10.0% |
| 64494 | Injections of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2021 | 11 | 14 | $6,851 | $618.90 | 9.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 23 | 114 | $547.20 | $100.90 | 18.4% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2021 | 20 | 51 | $70.38 | $16.66 | 23.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 362 | 1,602 | $641,107 | $131,358 | 20.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 316 | 1,059 | $276,750 | $58,220 | 21.0% |
| 80307 | Testing for presence of drug | Office | 2020 | 238 | 413 | $197,769 | $25,484 | 12.9% |
| 62323 | Injection of substance into spinal canal of lower back or sacrum using imaging guidance | Facility | 2020 | 58 | 82 | $67,233 | $6,490 | 9.7% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 78 | 78 | $30,334 | $5,667 | 18.7% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 36 | 54 | $22,008 | $2,798 | 12.7% |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance | Facility | 2020 | 19 | 23 | $23,198 | $2,180 | 9.4% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Office | 2020 | 13 | 59 | $9,682 | $1,847 | 19.1% |
| 64493 | Injections of lower or sacral spine facet joint using imaging guidance | Facility | 2020 | 15 | 19 | $15,733 | $1,462 | 9.3% |
About Dr. Brian Wiley, M.D
Dr. Brian Wiley, M.D is a Family Medicine healthcare provider based in Duncanville, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/22/2008. The National Provider Identifier (NPI) number assigned to this provider is 1346490851.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Wiley, M.D has received a total of $4,590 in payments from pharmaceutical and medical device companies, with $116.59 received in 2023. These payments were reported across 238 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($4,590).
As a Medicare-enrolled provider, Wiley has provided services to 2,096 Medicare beneficiaries, totaling 5,966 services with total Medicare billing of $407,635. Data is available for 2 years (2020–2021), covering 32 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Duncanville, TX
- Active Since 09/22/2008
- Last Updated 02/19/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1346490851
Products in Payments
- XTAMPZA (Drug) $430.09
- RELISTOR ORAL (Drug) $299.71
- Horizant (Drug) $254.14
- Morphabond ER (Drug) $227.69
- SUBSYS (Drug) $206.19
- ADAPTIVESTIM (Device) $205.99
- INTELLIS (Device) $205.81
- BUNAVAIL 2.1 mg 30-count box (Drug) $185.42
- Xtampza ER (Drug) $170.99
- LYRICA (Drug) $168.78
- Octrode SCS Leads (Device) $149.61
- Lucemyra/Lofexidine (Drug) $132.94
- Proclaim IPG (Device) $128.42
- BEXSERO (Biological) $124.72
- SHINGRIX (Biological) $116.59
- RELISTOR (Drug) $107.86
- SYNCHROMED (Device) $101.86
- Proclaim Family of SCS IPGs (Device) $99.23
- AJOVY (Drug) $94.14
- BELBUCA (Drug) $93.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Duncanville
Joe Phipps, D.o, D.O
Family Medicine — Payments: $664.77
Neethu Benny, Md, MD
Family Medicine — Payments: $196.35
Dr. Meredith Amos, M.d, M.D
Family Medicine — Payments: $32.29
Shola Akinfiresoye, Dnp, Fnp-Bc, DNP, FNP-BC
Family Medicine — Payments: $28.18
Dr. Don Christiansen, D.o, D.O
Family Medicine
Michael Freeman, Md, MD
Family Medicine